Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
60
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine – a Phase I trial

Sylvia Guetz1 Ev. Diakonissenkrankenhaus Leipzig, Leipzig
,
Amanda Tufman2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), Munich
,
Joachim von Pawel3 Asklepios Fachkliniken Muenchen-Gauting, Gauting
,
Achim Rittmeyer4 Lungenfachklinik Immenhausen, Immenhausen, Germany
,
Astrid Borgmeier2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), Munich
,
Pierre Ferré5 Pierre Fabre Pharmaceuticals, Oncology Research and Development Center, Toulouse, France
,
Birgit Edlich6 Pierre Fabre Pharma GmbH, Freiburg, Germany
&
Rudolf Maria Huber2 University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), MunichCorrespondence[email protected]
 show all
Pages 1081-1089 | Published online: 21 Feb 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.